Borgeson Blake 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Borgeson Blake
Director
Transactions
- Award
Class A Common Stock
2025-01-02+1,734→ 7,067,847 total
Footnotes (1)
- [F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.